Global Rare Kidney Diseases Treatment Supply, Demand and Key Producers, 2023-2029
The global Rare Kidney Diseases Treatment market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
This report studies the global Rare Kidney Diseases Treatment demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Rare Kidney Diseases Treatment, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Rare Kidney Diseases Treatment that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Rare Kidney Diseases Treatment total market, 2018-2029, (USD Million)
Global Rare Kidney Diseases Treatment total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Rare Kidney Diseases Treatment total market, key domestic companies and share, (USD Million)
Global Rare Kidney Diseases Treatment revenue by player and market share 2018-2023, (USD Million)
Global Rare Kidney Diseases Treatment total market by Drug Class, CAGR, 2018-2029, (USD Million)
Global Rare Kidney Diseases Treatment total market by Distribution Channel, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Rare Kidney Diseases Treatment market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Calliditas Therapeutics AB, GSK plc, Aurinia Pharmaceuticals, Inc., Amicus Therapeutics, Inc., Shire (Takeda Pharmaceutical Company Limited), Sanofi, Advicenne, Alexion Pharmaceuticals, Inc. and Horizon Therapeutics plc, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Rare Kidney Diseases Treatment market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Drug Class, and by Distribution Channel. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Rare Kidney Diseases Treatment Market, By Region:
1. How big is the global Rare Kidney Diseases Treatment market?
2. What is the demand of the global Rare Kidney Diseases Treatment market?
3. What is the year over year growth of the global Rare Kidney Diseases Treatment market?
4. What is the total value of the global Rare Kidney Diseases Treatment market?
5. Who are the major players in the global Rare Kidney Diseases Treatment market?
6. What are the growth factors driving the market demand?
This report studies the global Rare Kidney Diseases Treatment demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Rare Kidney Diseases Treatment, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Rare Kidney Diseases Treatment that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Rare Kidney Diseases Treatment total market, 2018-2029, (USD Million)
Global Rare Kidney Diseases Treatment total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Rare Kidney Diseases Treatment total market, key domestic companies and share, (USD Million)
Global Rare Kidney Diseases Treatment revenue by player and market share 2018-2023, (USD Million)
Global Rare Kidney Diseases Treatment total market by Drug Class, CAGR, 2018-2029, (USD Million)
Global Rare Kidney Diseases Treatment total market by Distribution Channel, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Rare Kidney Diseases Treatment market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Calliditas Therapeutics AB, GSK plc, Aurinia Pharmaceuticals, Inc., Amicus Therapeutics, Inc., Shire (Takeda Pharmaceutical Company Limited), Sanofi, Advicenne, Alexion Pharmaceuticals, Inc. and Horizon Therapeutics plc, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Rare Kidney Diseases Treatment market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Drug Class, and by Distribution Channel. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Rare Kidney Diseases Treatment Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Enzyme Replacement Therapy
- Monoclonal Antibodies
- Others
- Hospital Pharmacies
- Retail Pharmacies
- Online Sales
- Calliditas Therapeutics AB
- GSK plc
- Aurinia Pharmaceuticals, Inc.
- Amicus Therapeutics, Inc.
- Shire (Takeda Pharmaceutical Company Limited)
- Sanofi
- Advicenne
- Alexion Pharmaceuticals, Inc.
- Horizon Therapeutics plc
- Otsuka Pharmaceutical Co., Ltd.
- Reata Pharmaceuticals, Inc.
1. How big is the global Rare Kidney Diseases Treatment market?
2. What is the demand of the global Rare Kidney Diseases Treatment market?
3. What is the year over year growth of the global Rare Kidney Diseases Treatment market?
4. What is the total value of the global Rare Kidney Diseases Treatment market?
5. Who are the major players in the global Rare Kidney Diseases Treatment market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Rare Kidney Diseases Treatment Introduction
1.2 World Rare Kidney Diseases Treatment Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Rare Kidney Diseases Treatment Total Market by Region (by Headquarter Location)
1.3.1 World Rare Kidney Diseases Treatment Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Rare Kidney Diseases Treatment Market Size (2018-2029)
1.3.3 China Rare Kidney Diseases Treatment Market Size (2018-2029)
1.3.4 Europe Rare Kidney Diseases Treatment Market Size (2018-2029)
1.3.5 Japan Rare Kidney Diseases Treatment Market Size (2018-2029)
1.3.6 South Korea Rare Kidney Diseases Treatment Market Size (2018-2029)
1.3.7 ASEAN Rare Kidney Diseases Treatment Market Size (2018-2029)
1.3.8 India Rare Kidney Diseases Treatment Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Rare Kidney Diseases Treatment Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Rare Kidney Diseases Treatment Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Rare Kidney Diseases Treatment Consumption Value (2018-2029)
2.2 World Rare Kidney Diseases Treatment Consumption Value by Region
2.2.1 World Rare Kidney Diseases Treatment Consumption Value by Region (2018-2023)
2.2.2 World Rare Kidney Diseases Treatment Consumption Value Forecast by Region (2024-2029)
2.3 United States Rare Kidney Diseases Treatment Consumption Value (2018-2029)
2.4 China Rare Kidney Diseases Treatment Consumption Value (2018-2029)
2.5 Europe Rare Kidney Diseases Treatment Consumption Value (2018-2029)
2.6 Japan Rare Kidney Diseases Treatment Consumption Value (2018-2029)
2.7 South Korea Rare Kidney Diseases Treatment Consumption Value (2018-2029)
2.8 ASEAN Rare Kidney Diseases Treatment Consumption Value (2018-2029)
2.9 India Rare Kidney Diseases Treatment Consumption Value (2018-2029)
3 WORLD RARE KIDNEY DISEASES TREATMENT COMPANIES COMPETITIVE ANALYSIS
3.1 World Rare Kidney Diseases Treatment Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Rare Kidney Diseases Treatment Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Rare Kidney Diseases Treatment in 2022
3.2.3 Global Concentration Ratios (CR8) for Rare Kidney Diseases Treatment in 2022
3.3 Rare Kidney Diseases Treatment Company Evaluation Quadrant
3.4 Rare Kidney Diseases Treatment Market: Overall Company Footprint Analysis
3.4.1 Rare Kidney Diseases Treatment Market: Region Footprint
3.4.2 Rare Kidney Diseases Treatment Market: Company Product Type Footprint
3.4.3 Rare Kidney Diseases Treatment Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Rare Kidney Diseases Treatment Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Rare Kidney Diseases Treatment Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Rare Kidney Diseases Treatment Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Rare Kidney Diseases Treatment Consumption Value Comparison
4.2.1 United States VS China: Rare Kidney Diseases Treatment Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Rare Kidney Diseases Treatment Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Rare Kidney Diseases Treatment Companies and Market Share, 2018-2023
4.3.1 United States Based Rare Kidney Diseases Treatment Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Rare Kidney Diseases Treatment Revenue, (2018-2023)
4.4 China Based Companies Rare Kidney Diseases Treatment Revenue and Market Share, 2018-2023
4.4.1 China Based Rare Kidney Diseases Treatment Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Rare Kidney Diseases Treatment Revenue, (2018-2023)
4.5 Rest of World Based Rare Kidney Diseases Treatment Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Rare Kidney Diseases Treatment Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Rare Kidney Diseases Treatment Revenue, (2018-2023)
5 MARKET ANALYSIS BY DRUG CLASS
5.1 World Rare Kidney Diseases Treatment Market Size Overview by Drug Class: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Drug Class
5.2.1 Enzyme Replacement Therapy
5.2.2 Monoclonal Antibodies
5.2.3 Others
5.3 Market Segment by Drug Class
5.3.1 World Rare Kidney Diseases Treatment Market Size by Drug Class (2018-2023)
5.3.2 World Rare Kidney Diseases Treatment Market Size by Drug Class (2024-2029)
5.3.3 World Rare Kidney Diseases Treatment Market Size Market Share by Drug Class (2018-2029)
6 MARKET ANALYSIS BY DISTRIBUTION CHANNEL
6.1 World Rare Kidney Diseases Treatment Market Size Overview by Distribution Channel: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Distribution Channel
6.2.1 Hospital Pharmacies
6.2.2 Retail Pharmacies
6.2.3 Online Sales
6.3 Market Segment by Distribution Channel
6.3.1 World Rare Kidney Diseases Treatment Market Size by Distribution Channel (2018-2023)
6.3.2 World Rare Kidney Diseases Treatment Market Size by Distribution Channel (2024-2029)
6.3.3 World Rare Kidney Diseases Treatment Market Size by Distribution Channel (2018-2029)
7 COMPANY PROFILES
7.1 Calliditas Therapeutics AB
7.1.1 Calliditas Therapeutics AB Details
7.1.2 Calliditas Therapeutics AB Major Business
7.1.3 Calliditas Therapeutics AB Rare Kidney Diseases Treatment Product and Services
7.1.4 Calliditas Therapeutics AB Rare Kidney Diseases Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Calliditas Therapeutics AB Recent Developments/Updates
7.1.6 Calliditas Therapeutics AB Competitive Strengths & Weaknesses
7.2 GSK plc
7.2.1 GSK plc Details
7.2.2 GSK plc Major Business
7.2.3 GSK plc Rare Kidney Diseases Treatment Product and Services
7.2.4 GSK plc Rare Kidney Diseases Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 GSK plc Recent Developments/Updates
7.2.6 GSK plc Competitive Strengths & Weaknesses
7.3 Aurinia Pharmaceuticals, Inc.
7.3.1 Aurinia Pharmaceuticals, Inc. Details
7.3.2 Aurinia Pharmaceuticals, Inc. Major Business
7.3.3 Aurinia Pharmaceuticals, Inc. Rare Kidney Diseases Treatment Product and Services
7.3.4 Aurinia Pharmaceuticals, Inc. Rare Kidney Diseases Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Aurinia Pharmaceuticals, Inc. Recent Developments/Updates
7.3.6 Aurinia Pharmaceuticals, Inc. Competitive Strengths & Weaknesses
7.4 Amicus Therapeutics, Inc.
7.4.1 Amicus Therapeutics, Inc. Details
7.4.2 Amicus Therapeutics, Inc. Major Business
7.4.3 Amicus Therapeutics, Inc. Rare Kidney Diseases Treatment Product and Services
7.4.4 Amicus Therapeutics, Inc. Rare Kidney Diseases Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Amicus Therapeutics, Inc. Recent Developments/Updates
7.4.6 Amicus Therapeutics, Inc. Competitive Strengths & Weaknesses
7.5 Shire (Takeda Pharmaceutical Company Limited)
7.5.1 Shire (Takeda Pharmaceutical Company Limited) Details
7.5.2 Shire (Takeda Pharmaceutical Company Limited) Major Business
7.5.3 Shire (Takeda Pharmaceutical Company Limited) Rare Kidney Diseases Treatment Product and Services
7.5.4 Shire (Takeda Pharmaceutical Company Limited) Rare Kidney Diseases Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Shire (Takeda Pharmaceutical Company Limited) Recent Developments/Updates
7.5.6 Shire (Takeda Pharmaceutical Company Limited) Competitive Strengths & Weaknesses
7.6 Sanofi
7.6.1 Sanofi Details
7.6.2 Sanofi Major Business
7.6.3 Sanofi Rare Kidney Diseases Treatment Product and Services
7.6.4 Sanofi Rare Kidney Diseases Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Sanofi Recent Developments/Updates
7.6.6 Sanofi Competitive Strengths & Weaknesses
7.7 Advicenne
7.7.1 Advicenne Details
7.7.2 Advicenne Major Business
7.7.3 Advicenne Rare Kidney Diseases Treatment Product and Services
7.7.4 Advicenne Rare Kidney Diseases Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Advicenne Recent Developments/Updates
7.7.6 Advicenne Competitive Strengths & Weaknesses
7.8 Alexion Pharmaceuticals, Inc.
7.8.1 Alexion Pharmaceuticals, Inc. Details
7.8.2 Alexion Pharmaceuticals, Inc. Major Business
7.8.3 Alexion Pharmaceuticals, Inc. Rare Kidney Diseases Treatment Product and Services
7.8.4 Alexion Pharmaceuticals, Inc. Rare Kidney Diseases Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Alexion Pharmaceuticals, Inc. Recent Developments/Updates
7.8.6 Alexion Pharmaceuticals, Inc. Competitive Strengths & Weaknesses
7.9 Horizon Therapeutics plc
7.9.1 Horizon Therapeutics plc Details
7.9.2 Horizon Therapeutics plc Major Business
7.9.3 Horizon Therapeutics plc Rare Kidney Diseases Treatment Product and Services
7.9.4 Horizon Therapeutics plc Rare Kidney Diseases Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Horizon Therapeutics plc Recent Developments/Updates
7.9.6 Horizon Therapeutics plc Competitive Strengths & Weaknesses
7.10 Otsuka Pharmaceutical Co., Ltd.
7.10.1 Otsuka Pharmaceutical Co., Ltd. Details
7.10.2 Otsuka Pharmaceutical Co., Ltd. Major Business
7.10.3 Otsuka Pharmaceutical Co., Ltd. Rare Kidney Diseases Treatment Product and Services
7.10.4 Otsuka Pharmaceutical Co., Ltd. Rare Kidney Diseases Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Otsuka Pharmaceutical Co., Ltd. Recent Developments/Updates
7.10.6 Otsuka Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
7.11 Reata Pharmaceuticals, Inc.
7.11.1 Reata Pharmaceuticals, Inc. Details
7.11.2 Reata Pharmaceuticals, Inc. Major Business
7.11.3 Reata Pharmaceuticals, Inc. Rare Kidney Diseases Treatment Product and Services
7.11.4 Reata Pharmaceuticals, Inc. Rare Kidney Diseases Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Reata Pharmaceuticals, Inc. Recent Developments/Updates
7.11.6 Reata Pharmaceuticals, Inc. Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Rare Kidney Diseases Treatment Industry Chain
8.2 Rare Kidney Diseases Treatment Upstream Analysis
8.3 Rare Kidney Diseases Treatment Midstream Analysis
8.4 Rare Kidney Diseases Treatment Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Rare Kidney Diseases Treatment Introduction
1.2 World Rare Kidney Diseases Treatment Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Rare Kidney Diseases Treatment Total Market by Region (by Headquarter Location)
1.3.1 World Rare Kidney Diseases Treatment Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Rare Kidney Diseases Treatment Market Size (2018-2029)
1.3.3 China Rare Kidney Diseases Treatment Market Size (2018-2029)
1.3.4 Europe Rare Kidney Diseases Treatment Market Size (2018-2029)
1.3.5 Japan Rare Kidney Diseases Treatment Market Size (2018-2029)
1.3.6 South Korea Rare Kidney Diseases Treatment Market Size (2018-2029)
1.3.7 ASEAN Rare Kidney Diseases Treatment Market Size (2018-2029)
1.3.8 India Rare Kidney Diseases Treatment Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Rare Kidney Diseases Treatment Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Rare Kidney Diseases Treatment Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Rare Kidney Diseases Treatment Consumption Value (2018-2029)
2.2 World Rare Kidney Diseases Treatment Consumption Value by Region
2.2.1 World Rare Kidney Diseases Treatment Consumption Value by Region (2018-2023)
2.2.2 World Rare Kidney Diseases Treatment Consumption Value Forecast by Region (2024-2029)
2.3 United States Rare Kidney Diseases Treatment Consumption Value (2018-2029)
2.4 China Rare Kidney Diseases Treatment Consumption Value (2018-2029)
2.5 Europe Rare Kidney Diseases Treatment Consumption Value (2018-2029)
2.6 Japan Rare Kidney Diseases Treatment Consumption Value (2018-2029)
2.7 South Korea Rare Kidney Diseases Treatment Consumption Value (2018-2029)
2.8 ASEAN Rare Kidney Diseases Treatment Consumption Value (2018-2029)
2.9 India Rare Kidney Diseases Treatment Consumption Value (2018-2029)
3 WORLD RARE KIDNEY DISEASES TREATMENT COMPANIES COMPETITIVE ANALYSIS
3.1 World Rare Kidney Diseases Treatment Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Rare Kidney Diseases Treatment Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Rare Kidney Diseases Treatment in 2022
3.2.3 Global Concentration Ratios (CR8) for Rare Kidney Diseases Treatment in 2022
3.3 Rare Kidney Diseases Treatment Company Evaluation Quadrant
3.4 Rare Kidney Diseases Treatment Market: Overall Company Footprint Analysis
3.4.1 Rare Kidney Diseases Treatment Market: Region Footprint
3.4.2 Rare Kidney Diseases Treatment Market: Company Product Type Footprint
3.4.3 Rare Kidney Diseases Treatment Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Rare Kidney Diseases Treatment Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Rare Kidney Diseases Treatment Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Rare Kidney Diseases Treatment Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Rare Kidney Diseases Treatment Consumption Value Comparison
4.2.1 United States VS China: Rare Kidney Diseases Treatment Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Rare Kidney Diseases Treatment Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Rare Kidney Diseases Treatment Companies and Market Share, 2018-2023
4.3.1 United States Based Rare Kidney Diseases Treatment Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Rare Kidney Diseases Treatment Revenue, (2018-2023)
4.4 China Based Companies Rare Kidney Diseases Treatment Revenue and Market Share, 2018-2023
4.4.1 China Based Rare Kidney Diseases Treatment Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Rare Kidney Diseases Treatment Revenue, (2018-2023)
4.5 Rest of World Based Rare Kidney Diseases Treatment Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Rare Kidney Diseases Treatment Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Rare Kidney Diseases Treatment Revenue, (2018-2023)
5 MARKET ANALYSIS BY DRUG CLASS
5.1 World Rare Kidney Diseases Treatment Market Size Overview by Drug Class: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Drug Class
5.2.1 Enzyme Replacement Therapy
5.2.2 Monoclonal Antibodies
5.2.3 Others
5.3 Market Segment by Drug Class
5.3.1 World Rare Kidney Diseases Treatment Market Size by Drug Class (2018-2023)
5.3.2 World Rare Kidney Diseases Treatment Market Size by Drug Class (2024-2029)
5.3.3 World Rare Kidney Diseases Treatment Market Size Market Share by Drug Class (2018-2029)
6 MARKET ANALYSIS BY DISTRIBUTION CHANNEL
6.1 World Rare Kidney Diseases Treatment Market Size Overview by Distribution Channel: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Distribution Channel
6.2.1 Hospital Pharmacies
6.2.2 Retail Pharmacies
6.2.3 Online Sales
6.3 Market Segment by Distribution Channel
6.3.1 World Rare Kidney Diseases Treatment Market Size by Distribution Channel (2018-2023)
6.3.2 World Rare Kidney Diseases Treatment Market Size by Distribution Channel (2024-2029)
6.3.3 World Rare Kidney Diseases Treatment Market Size by Distribution Channel (2018-2029)
7 COMPANY PROFILES
7.1 Calliditas Therapeutics AB
7.1.1 Calliditas Therapeutics AB Details
7.1.2 Calliditas Therapeutics AB Major Business
7.1.3 Calliditas Therapeutics AB Rare Kidney Diseases Treatment Product and Services
7.1.4 Calliditas Therapeutics AB Rare Kidney Diseases Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Calliditas Therapeutics AB Recent Developments/Updates
7.1.6 Calliditas Therapeutics AB Competitive Strengths & Weaknesses
7.2 GSK plc
7.2.1 GSK plc Details
7.2.2 GSK plc Major Business
7.2.3 GSK plc Rare Kidney Diseases Treatment Product and Services
7.2.4 GSK plc Rare Kidney Diseases Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 GSK plc Recent Developments/Updates
7.2.6 GSK plc Competitive Strengths & Weaknesses
7.3 Aurinia Pharmaceuticals, Inc.
7.3.1 Aurinia Pharmaceuticals, Inc. Details
7.3.2 Aurinia Pharmaceuticals, Inc. Major Business
7.3.3 Aurinia Pharmaceuticals, Inc. Rare Kidney Diseases Treatment Product and Services
7.3.4 Aurinia Pharmaceuticals, Inc. Rare Kidney Diseases Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Aurinia Pharmaceuticals, Inc. Recent Developments/Updates
7.3.6 Aurinia Pharmaceuticals, Inc. Competitive Strengths & Weaknesses
7.4 Amicus Therapeutics, Inc.
7.4.1 Amicus Therapeutics, Inc. Details
7.4.2 Amicus Therapeutics, Inc. Major Business
7.4.3 Amicus Therapeutics, Inc. Rare Kidney Diseases Treatment Product and Services
7.4.4 Amicus Therapeutics, Inc. Rare Kidney Diseases Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Amicus Therapeutics, Inc. Recent Developments/Updates
7.4.6 Amicus Therapeutics, Inc. Competitive Strengths & Weaknesses
7.5 Shire (Takeda Pharmaceutical Company Limited)
7.5.1 Shire (Takeda Pharmaceutical Company Limited) Details
7.5.2 Shire (Takeda Pharmaceutical Company Limited) Major Business
7.5.3 Shire (Takeda Pharmaceutical Company Limited) Rare Kidney Diseases Treatment Product and Services
7.5.4 Shire (Takeda Pharmaceutical Company Limited) Rare Kidney Diseases Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Shire (Takeda Pharmaceutical Company Limited) Recent Developments/Updates
7.5.6 Shire (Takeda Pharmaceutical Company Limited) Competitive Strengths & Weaknesses
7.6 Sanofi
7.6.1 Sanofi Details
7.6.2 Sanofi Major Business
7.6.3 Sanofi Rare Kidney Diseases Treatment Product and Services
7.6.4 Sanofi Rare Kidney Diseases Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Sanofi Recent Developments/Updates
7.6.6 Sanofi Competitive Strengths & Weaknesses
7.7 Advicenne
7.7.1 Advicenne Details
7.7.2 Advicenne Major Business
7.7.3 Advicenne Rare Kidney Diseases Treatment Product and Services
7.7.4 Advicenne Rare Kidney Diseases Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Advicenne Recent Developments/Updates
7.7.6 Advicenne Competitive Strengths & Weaknesses
7.8 Alexion Pharmaceuticals, Inc.
7.8.1 Alexion Pharmaceuticals, Inc. Details
7.8.2 Alexion Pharmaceuticals, Inc. Major Business
7.8.3 Alexion Pharmaceuticals, Inc. Rare Kidney Diseases Treatment Product and Services
7.8.4 Alexion Pharmaceuticals, Inc. Rare Kidney Diseases Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Alexion Pharmaceuticals, Inc. Recent Developments/Updates
7.8.6 Alexion Pharmaceuticals, Inc. Competitive Strengths & Weaknesses
7.9 Horizon Therapeutics plc
7.9.1 Horizon Therapeutics plc Details
7.9.2 Horizon Therapeutics plc Major Business
7.9.3 Horizon Therapeutics plc Rare Kidney Diseases Treatment Product and Services
7.9.4 Horizon Therapeutics plc Rare Kidney Diseases Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Horizon Therapeutics plc Recent Developments/Updates
7.9.6 Horizon Therapeutics plc Competitive Strengths & Weaknesses
7.10 Otsuka Pharmaceutical Co., Ltd.
7.10.1 Otsuka Pharmaceutical Co., Ltd. Details
7.10.2 Otsuka Pharmaceutical Co., Ltd. Major Business
7.10.3 Otsuka Pharmaceutical Co., Ltd. Rare Kidney Diseases Treatment Product and Services
7.10.4 Otsuka Pharmaceutical Co., Ltd. Rare Kidney Diseases Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Otsuka Pharmaceutical Co., Ltd. Recent Developments/Updates
7.10.6 Otsuka Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
7.11 Reata Pharmaceuticals, Inc.
7.11.1 Reata Pharmaceuticals, Inc. Details
7.11.2 Reata Pharmaceuticals, Inc. Major Business
7.11.3 Reata Pharmaceuticals, Inc. Rare Kidney Diseases Treatment Product and Services
7.11.4 Reata Pharmaceuticals, Inc. Rare Kidney Diseases Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Reata Pharmaceuticals, Inc. Recent Developments/Updates
7.11.6 Reata Pharmaceuticals, Inc. Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Rare Kidney Diseases Treatment Industry Chain
8.2 Rare Kidney Diseases Treatment Upstream Analysis
8.3 Rare Kidney Diseases Treatment Midstream Analysis
8.4 Rare Kidney Diseases Treatment Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Rare Kidney Diseases Treatment Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Rare Kidney Diseases Treatment Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Rare Kidney Diseases Treatment Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Rare Kidney Diseases Treatment Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Rare Kidney Diseases Treatment Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Rare Kidney Diseases Treatment Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Rare Kidney Diseases Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Rare Kidney Diseases Treatment Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Rare Kidney Diseases Treatment Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Rare Kidney Diseases Treatment Players in 2022
Table 12. World Rare Kidney Diseases Treatment Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Rare Kidney Diseases Treatment Company Evaluation Quadrant
Table 14. Head Office of Key Rare Kidney Diseases Treatment Player
Table 15. Rare Kidney Diseases Treatment Market: Company Product Type Footprint
Table 16. Rare Kidney Diseases Treatment Market: Company Product Application Footprint
Table 17. Rare Kidney Diseases Treatment Mergers & Acquisitions Activity
Table 18. United States VS China Rare Kidney Diseases Treatment Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Rare Kidney Diseases Treatment Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Rare Kidney Diseases Treatment Companies, Headquarters (States, Country)
Table 21. United States Based Companies Rare Kidney Diseases Treatment Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Rare Kidney Diseases Treatment Revenue Market Share (2018-2023)
Table 23. China Based Rare Kidney Diseases Treatment Companies, Headquarters (Province, Country)
Table 24. China Based Companies Rare Kidney Diseases Treatment Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Rare Kidney Diseases Treatment Revenue Market Share (2018-2023)
Table 26. Rest of World Based Rare Kidney Diseases Treatment Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Rare Kidney Diseases Treatment Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Rare Kidney Diseases Treatment Revenue Market Share (2018-2023)
Table 29. World Rare Kidney Diseases Treatment Market Size by Drug Class, (USD Million), 2018 & 2022 & 2029
Table 30. World Rare Kidney Diseases Treatment Market Size by Drug Class (2018-2023) & (USD Million)
Table 31. World Rare Kidney Diseases Treatment Market Size by Drug Class (2024-2029) & (USD Million)
Table 32. World Rare Kidney Diseases Treatment Market Size by Distribution Channel, (USD Million), 2018 & 2022 & 2029
Table 33. World Rare Kidney Diseases Treatment Market Size by Distribution Channel (2018-2023) & (USD Million)
Table 34. World Rare Kidney Diseases Treatment Market Size by Distribution Channel (2024-2029) & (USD Million)
Table 35. Calliditas Therapeutics AB Basic Information, Area Served and Competitors
Table 36. Calliditas Therapeutics AB Major Business
Table 37. Calliditas Therapeutics AB Rare Kidney Diseases Treatment Product and Services
Table 38. Calliditas Therapeutics AB Rare Kidney Diseases Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Calliditas Therapeutics AB Recent Developments/Updates
Table 40. Calliditas Therapeutics AB Competitive Strengths & Weaknesses
Table 41. GSK plc Basic Information, Area Served and Competitors
Table 42. GSK plc Major Business
Table 43. GSK plc Rare Kidney Diseases Treatment Product and Services
Table 44. GSK plc Rare Kidney Diseases Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. GSK plc Recent Developments/Updates
Table 46. GSK plc Competitive Strengths & Weaknesses
Table 47. Aurinia Pharmaceuticals, Inc. Basic Information, Area Served and Competitors
Table 48. Aurinia Pharmaceuticals, Inc. Major Business
Table 49. Aurinia Pharmaceuticals, Inc. Rare Kidney Diseases Treatment Product and Services
Table 50. Aurinia Pharmaceuticals, Inc. Rare Kidney Diseases Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Aurinia Pharmaceuticals, Inc. Recent Developments/Updates
Table 52. Aurinia Pharmaceuticals, Inc. Competitive Strengths & Weaknesses
Table 53. Amicus Therapeutics, Inc. Basic Information, Area Served and Competitors
Table 54. Amicus Therapeutics, Inc. Major Business
Table 55. Amicus Therapeutics, Inc. Rare Kidney Diseases Treatment Product and Services
Table 56. Amicus Therapeutics, Inc. Rare Kidney Diseases Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Amicus Therapeutics, Inc. Recent Developments/Updates
Table 58. Amicus Therapeutics, Inc. Competitive Strengths & Weaknesses
Table 59. Shire (Takeda Pharmaceutical Company Limited) Basic Information, Area Served and Competitors
Table 60. Shire (Takeda Pharmaceutical Company Limited) Major Business
Table 61. Shire (Takeda Pharmaceutical Company Limited) Rare Kidney Diseases Treatment Product and Services
Table 62. Shire (Takeda Pharmaceutical Company Limited) Rare Kidney Diseases Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Shire (Takeda Pharmaceutical Company Limited) Recent Developments/Updates
Table 64. Shire (Takeda Pharmaceutical Company Limited) Competitive Strengths & Weaknesses
Table 65. Sanofi Basic Information, Area Served and Competitors
Table 66. Sanofi Major Business
Table 67. Sanofi Rare Kidney Diseases Treatment Product and Services
Table 68. Sanofi Rare Kidney Diseases Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Sanofi Recent Developments/Updates
Table 70. Sanofi Competitive Strengths & Weaknesses
Table 71. Advicenne Basic Information, Area Served and Competitors
Table 72. Advicenne Major Business
Table 73. Advicenne Rare Kidney Diseases Treatment Product and Services
Table 74. Advicenne Rare Kidney Diseases Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Advicenne Recent Developments/Updates
Table 76. Advicenne Competitive Strengths & Weaknesses
Table 77. Alexion Pharmaceuticals, Inc. Basic Information, Area Served and Competitors
Table 78. Alexion Pharmaceuticals, Inc. Major Business
Table 79. Alexion Pharmaceuticals, Inc. Rare Kidney Diseases Treatment Product and Services
Table 80. Alexion Pharmaceuticals, Inc. Rare Kidney Diseases Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Alexion Pharmaceuticals, Inc. Recent Developments/Updates
Table 82. Alexion Pharmaceuticals, Inc. Competitive Strengths & Weaknesses
Table 83. Horizon Therapeutics plc Basic Information, Area Served and Competitors
Table 84. Horizon Therapeutics plc Major Business
Table 85. Horizon Therapeutics plc Rare Kidney Diseases Treatment Product and Services
Table 86. Horizon Therapeutics plc Rare Kidney Diseases Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Horizon Therapeutics plc Recent Developments/Updates
Table 88. Horizon Therapeutics plc Competitive Strengths & Weaknesses
Table 89. Otsuka Pharmaceutical Co., Ltd. Basic Information, Area Served and Competitors
Table 90. Otsuka Pharmaceutical Co., Ltd. Major Business
Table 91. Otsuka Pharmaceutical Co., Ltd. Rare Kidney Diseases Treatment Product and Services
Table 92. Otsuka Pharmaceutical Co., Ltd. Rare Kidney Diseases Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Otsuka Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 94. Reata Pharmaceuticals, Inc. Basic Information, Area Served and Competitors
Table 95. Reata Pharmaceuticals, Inc. Major Business
Table 96. Reata Pharmaceuticals, Inc. Rare Kidney Diseases Treatment Product and Services
Table 97. Reata Pharmaceuticals, Inc. Rare Kidney Diseases Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 98. Global Key Players of Rare Kidney Diseases Treatment Upstream (Raw Materials)
Table 99. Rare Kidney Diseases Treatment Typical Customers
Table 1. World Rare Kidney Diseases Treatment Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Rare Kidney Diseases Treatment Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Rare Kidney Diseases Treatment Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Rare Kidney Diseases Treatment Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Rare Kidney Diseases Treatment Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Rare Kidney Diseases Treatment Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Rare Kidney Diseases Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Rare Kidney Diseases Treatment Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Rare Kidney Diseases Treatment Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Rare Kidney Diseases Treatment Players in 2022
Table 12. World Rare Kidney Diseases Treatment Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Rare Kidney Diseases Treatment Company Evaluation Quadrant
Table 14. Head Office of Key Rare Kidney Diseases Treatment Player
Table 15. Rare Kidney Diseases Treatment Market: Company Product Type Footprint
Table 16. Rare Kidney Diseases Treatment Market: Company Product Application Footprint
Table 17. Rare Kidney Diseases Treatment Mergers & Acquisitions Activity
Table 18. United States VS China Rare Kidney Diseases Treatment Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Rare Kidney Diseases Treatment Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Rare Kidney Diseases Treatment Companies, Headquarters (States, Country)
Table 21. United States Based Companies Rare Kidney Diseases Treatment Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Rare Kidney Diseases Treatment Revenue Market Share (2018-2023)
Table 23. China Based Rare Kidney Diseases Treatment Companies, Headquarters (Province, Country)
Table 24. China Based Companies Rare Kidney Diseases Treatment Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Rare Kidney Diseases Treatment Revenue Market Share (2018-2023)
Table 26. Rest of World Based Rare Kidney Diseases Treatment Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Rare Kidney Diseases Treatment Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Rare Kidney Diseases Treatment Revenue Market Share (2018-2023)
Table 29. World Rare Kidney Diseases Treatment Market Size by Drug Class, (USD Million), 2018 & 2022 & 2029
Table 30. World Rare Kidney Diseases Treatment Market Size by Drug Class (2018-2023) & (USD Million)
Table 31. World Rare Kidney Diseases Treatment Market Size by Drug Class (2024-2029) & (USD Million)
Table 32. World Rare Kidney Diseases Treatment Market Size by Distribution Channel, (USD Million), 2018 & 2022 & 2029
Table 33. World Rare Kidney Diseases Treatment Market Size by Distribution Channel (2018-2023) & (USD Million)
Table 34. World Rare Kidney Diseases Treatment Market Size by Distribution Channel (2024-2029) & (USD Million)
Table 35. Calliditas Therapeutics AB Basic Information, Area Served and Competitors
Table 36. Calliditas Therapeutics AB Major Business
Table 37. Calliditas Therapeutics AB Rare Kidney Diseases Treatment Product and Services
Table 38. Calliditas Therapeutics AB Rare Kidney Diseases Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Calliditas Therapeutics AB Recent Developments/Updates
Table 40. Calliditas Therapeutics AB Competitive Strengths & Weaknesses
Table 41. GSK plc Basic Information, Area Served and Competitors
Table 42. GSK plc Major Business
Table 43. GSK plc Rare Kidney Diseases Treatment Product and Services
Table 44. GSK plc Rare Kidney Diseases Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. GSK plc Recent Developments/Updates
Table 46. GSK plc Competitive Strengths & Weaknesses
Table 47. Aurinia Pharmaceuticals, Inc. Basic Information, Area Served and Competitors
Table 48. Aurinia Pharmaceuticals, Inc. Major Business
Table 49. Aurinia Pharmaceuticals, Inc. Rare Kidney Diseases Treatment Product and Services
Table 50. Aurinia Pharmaceuticals, Inc. Rare Kidney Diseases Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Aurinia Pharmaceuticals, Inc. Recent Developments/Updates
Table 52. Aurinia Pharmaceuticals, Inc. Competitive Strengths & Weaknesses
Table 53. Amicus Therapeutics, Inc. Basic Information, Area Served and Competitors
Table 54. Amicus Therapeutics, Inc. Major Business
Table 55. Amicus Therapeutics, Inc. Rare Kidney Diseases Treatment Product and Services
Table 56. Amicus Therapeutics, Inc. Rare Kidney Diseases Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Amicus Therapeutics, Inc. Recent Developments/Updates
Table 58. Amicus Therapeutics, Inc. Competitive Strengths & Weaknesses
Table 59. Shire (Takeda Pharmaceutical Company Limited) Basic Information, Area Served and Competitors
Table 60. Shire (Takeda Pharmaceutical Company Limited) Major Business
Table 61. Shire (Takeda Pharmaceutical Company Limited) Rare Kidney Diseases Treatment Product and Services
Table 62. Shire (Takeda Pharmaceutical Company Limited) Rare Kidney Diseases Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Shire (Takeda Pharmaceutical Company Limited) Recent Developments/Updates
Table 64. Shire (Takeda Pharmaceutical Company Limited) Competitive Strengths & Weaknesses
Table 65. Sanofi Basic Information, Area Served and Competitors
Table 66. Sanofi Major Business
Table 67. Sanofi Rare Kidney Diseases Treatment Product and Services
Table 68. Sanofi Rare Kidney Diseases Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Sanofi Recent Developments/Updates
Table 70. Sanofi Competitive Strengths & Weaknesses
Table 71. Advicenne Basic Information, Area Served and Competitors
Table 72. Advicenne Major Business
Table 73. Advicenne Rare Kidney Diseases Treatment Product and Services
Table 74. Advicenne Rare Kidney Diseases Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Advicenne Recent Developments/Updates
Table 76. Advicenne Competitive Strengths & Weaknesses
Table 77. Alexion Pharmaceuticals, Inc. Basic Information, Area Served and Competitors
Table 78. Alexion Pharmaceuticals, Inc. Major Business
Table 79. Alexion Pharmaceuticals, Inc. Rare Kidney Diseases Treatment Product and Services
Table 80. Alexion Pharmaceuticals, Inc. Rare Kidney Diseases Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Alexion Pharmaceuticals, Inc. Recent Developments/Updates
Table 82. Alexion Pharmaceuticals, Inc. Competitive Strengths & Weaknesses
Table 83. Horizon Therapeutics plc Basic Information, Area Served and Competitors
Table 84. Horizon Therapeutics plc Major Business
Table 85. Horizon Therapeutics plc Rare Kidney Diseases Treatment Product and Services
Table 86. Horizon Therapeutics plc Rare Kidney Diseases Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Horizon Therapeutics plc Recent Developments/Updates
Table 88. Horizon Therapeutics plc Competitive Strengths & Weaknesses
Table 89. Otsuka Pharmaceutical Co., Ltd. Basic Information, Area Served and Competitors
Table 90. Otsuka Pharmaceutical Co., Ltd. Major Business
Table 91. Otsuka Pharmaceutical Co., Ltd. Rare Kidney Diseases Treatment Product and Services
Table 92. Otsuka Pharmaceutical Co., Ltd. Rare Kidney Diseases Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Otsuka Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 94. Reata Pharmaceuticals, Inc. Basic Information, Area Served and Competitors
Table 95. Reata Pharmaceuticals, Inc. Major Business
Table 96. Reata Pharmaceuticals, Inc. Rare Kidney Diseases Treatment Product and Services
Table 97. Reata Pharmaceuticals, Inc. Rare Kidney Diseases Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 98. Global Key Players of Rare Kidney Diseases Treatment Upstream (Raw Materials)
Table 99. Rare Kidney Diseases Treatment Typical Customers
LIST OF FIGURES
Figure 1. Rare Kidney Diseases Treatment Picture
Figure 2. World Rare Kidney Diseases Treatment Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Rare Kidney Diseases Treatment Total Market Size (2018-2029) & (USD Million)
Figure 4. World Rare Kidney Diseases Treatment Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Rare Kidney Diseases Treatment Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Rare Kidney Diseases Treatment Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Rare Kidney Diseases Treatment Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Rare Kidney Diseases Treatment Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Rare Kidney Diseases Treatment Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Rare Kidney Diseases Treatment Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Rare Kidney Diseases Treatment Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Rare Kidney Diseases Treatment Revenue (2018-2029) & (USD Million)
Figure 13. Rare Kidney Diseases Treatment Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Rare Kidney Diseases Treatment Consumption Value (2018-2029) & (USD Million)
Figure 16. World Rare Kidney Diseases Treatment Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Rare Kidney Diseases Treatment Consumption Value (2018-2029) & (USD Million)
Figure 18. China Rare Kidney Diseases Treatment Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Rare Kidney Diseases Treatment Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Rare Kidney Diseases Treatment Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Rare Kidney Diseases Treatment Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Rare Kidney Diseases Treatment Consumption Value (2018-2029) & (USD Million)
Figure 23. India Rare Kidney Diseases Treatment Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Rare Kidney Diseases Treatment by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Rare Kidney Diseases Treatment Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Rare Kidney Diseases Treatment Markets in 2022
Figure 27. United States VS China: Rare Kidney Diseases Treatment Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Rare Kidney Diseases Treatment Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Rare Kidney Diseases Treatment Market Size by Drug Class, (USD Million), 2018 & 2022 & 2029
Figure 30. World Rare Kidney Diseases Treatment Market Size Market Share by Drug Class in 2022
Figure 31. Enzyme Replacement Therapy
Figure 32. Monoclonal Antibodies
Figure 33. Others
Figure 34. World Rare Kidney Diseases Treatment Market Size Market Share by Drug Class (2018-2029)
Figure 35. World Rare Kidney Diseases Treatment Market Size by Distribution Channel, (USD Million), 2018 & 2022 & 2029
Figure 36. World Rare Kidney Diseases Treatment Market Size Market Share by Distribution Channel in 2022
Figure 37. Hospital Pharmacies
Figure 38. Retail Pharmacies
Figure 39. Online Sales
Figure 40. Rare Kidney Diseases Treatment Industrial Chain
Figure 41. Methodology
Figure 42. Research Process and Data Source
Figure 1. Rare Kidney Diseases Treatment Picture
Figure 2. World Rare Kidney Diseases Treatment Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Rare Kidney Diseases Treatment Total Market Size (2018-2029) & (USD Million)
Figure 4. World Rare Kidney Diseases Treatment Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Rare Kidney Diseases Treatment Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Rare Kidney Diseases Treatment Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Rare Kidney Diseases Treatment Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Rare Kidney Diseases Treatment Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Rare Kidney Diseases Treatment Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Rare Kidney Diseases Treatment Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Rare Kidney Diseases Treatment Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Rare Kidney Diseases Treatment Revenue (2018-2029) & (USD Million)
Figure 13. Rare Kidney Diseases Treatment Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Rare Kidney Diseases Treatment Consumption Value (2018-2029) & (USD Million)
Figure 16. World Rare Kidney Diseases Treatment Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Rare Kidney Diseases Treatment Consumption Value (2018-2029) & (USD Million)
Figure 18. China Rare Kidney Diseases Treatment Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Rare Kidney Diseases Treatment Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Rare Kidney Diseases Treatment Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Rare Kidney Diseases Treatment Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Rare Kidney Diseases Treatment Consumption Value (2018-2029) & (USD Million)
Figure 23. India Rare Kidney Diseases Treatment Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Rare Kidney Diseases Treatment by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Rare Kidney Diseases Treatment Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Rare Kidney Diseases Treatment Markets in 2022
Figure 27. United States VS China: Rare Kidney Diseases Treatment Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Rare Kidney Diseases Treatment Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Rare Kidney Diseases Treatment Market Size by Drug Class, (USD Million), 2018 & 2022 & 2029
Figure 30. World Rare Kidney Diseases Treatment Market Size Market Share by Drug Class in 2022
Figure 31. Enzyme Replacement Therapy
Figure 32. Monoclonal Antibodies
Figure 33. Others
Figure 34. World Rare Kidney Diseases Treatment Market Size Market Share by Drug Class (2018-2029)
Figure 35. World Rare Kidney Diseases Treatment Market Size by Distribution Channel, (USD Million), 2018 & 2022 & 2029
Figure 36. World Rare Kidney Diseases Treatment Market Size Market Share by Distribution Channel in 2022
Figure 37. Hospital Pharmacies
Figure 38. Retail Pharmacies
Figure 39. Online Sales
Figure 40. Rare Kidney Diseases Treatment Industrial Chain
Figure 41. Methodology
Figure 42. Research Process and Data Source
